Share：
Share this content in WeChat
X
[Chinese][PDF]69719
• Clinical Article •
Histogram features of quantitative parameters from synthetic MRI and ADC map in predicting the expression of Ki-67 in breast cancer
LI Fangzheng  LI Qin  WU Shasha  SUN Shengjun  YU Haitong  CHEN Yongsheng  NIU Qingliang 

Cite this article as: Li FZ, Li Q, Wu SS, et al. Histogram features of quantitative parameters from synthetic MRI and ADC map in predicting the expression of Ki-67 in breast cancer[J]. Chin J Magn Reson Imaging, 2022, 13(7): 29-34, 67. DOI:10.12015/issn.1674-8034.2022.07.006.


[Abstract] Objective To evaluate the value of the histogram features of quantitative parameters from synthetic MRI and apparent diffusion coefficient (ADC) in predicting the expression of Ki-67 in breast cancer.Materials and Methods The clinical and imaging data of 146 patients with breast cancer confirmed by pathology in our hospital from December 2019 to March 2021 were retrospectively analyzed. All patients underwent MRI routine sequence imaging, dynamic contrast-enhanced MRI (DCE-MRI) and synthetic MRI sequence scan imaging before biopsy or surgery. The histogram features of the quantitative parameters T1、T2、proton density (PD) of synthetic MRI and ADC values were extracted by PyRadiomics software. According to the expression of Ki-67, breast cancer patients were divided into high expression group (≥30%) and low expression group (＜30%). The χ2 test, independent sample t-test or Mann-Whitney U test were used to compare the differences of clinical and pathological characteristics, the histogram features of synthetic MRI quantitative parameter maps (T1-mapping, T2-mapping, PD-mapping) and ADC map between the two groups. Logistic regression analysis was used to analyze the relationship between the expression status of Ki-67 in breast cancer and quantitative parameters of MRI, and drawn the receiver operating characteristic (ROC) curve, calculated the area under curve (AUC) to compare the predictive efficacy of each histogram feature in predicting the expression status of Ki-67.Results Univariate logistic analysis showed that there were no significant differences in the histogram characteristics of ADC map, clinical and pathological characteristics between the high and low expression groups of Ki-67 (age, P=0.13; maximum diameter, P=0.09; shape, P=0.94; border, P=0.23; reinforcement mode, P=0.13; fibrous gland type, P=0.26). There was statistically significant difference in T1- mean, T1-10th percentile, T2- mean, T2-10th percentile, PD-entropy, and PD-kurtosis between the high and low expression groups Ki-67 in breast cancer (P＜0.01). Multivariate logistic analysis showed that T1-10th percentile and T2-10th percentile were independent predictors for Ki-67 expression states. The AUC of predicting Ki-67 expression by the model constructed by the two parameters was 0.809, with the sensitivity of 64.8%, the specificity of 87.5% and the accuracy of 72.8%.Conclusions The quantitative parameters of synthetic MRI can help predict the expression of Ki-67 in breast cancer and provide an effective auxiliary diagnosis method for preoperative non-invasive evaluation of tumor proliferation.
[Keywords] breast cancer；magnetic resonance imaging；quantitative；synthetic magnetic resonance imaging；Ki-67

LI Fangzheng1   LI Qin2   WU Shasha2   SUN Shengjun1   YU Haitong1   CHEN Yongsheng2   NIU Qingliang2*  

1 School of Medical Imaging, Weifang Medical College, Weifang 261053, China

2 Center of Medical Imaging, Weifang Traditional Chinese Medicine Hospital, Weifang 261041, China

NIU QL, E-mail: qingliangniu@126.com

Conflicts of interest   None.

ACKNOWLEDGMENTS Shandong Province Natural Science Foundation (No. ZR202103060229).
Received  2022-03-28
Accepted  2022-07-01
DOI: 10.12015/issn.1674-8034.2022.07.006
Cite this article as: Li FZ, Li Q, Wu SS, et al. Histogram features of quantitative parameters from synthetic MRI and ADC map in predicting the expression of Ki-67 in breast cancer[J]. Chin J Magn Reson Imaging, 2022, 13(7): 29-34, 67. DOI:10.12015/issn.1674-8034.2022.07.006.

[1]
Setyawati Y, Rahmawati Y, Widodo I, et al. The association between molecular subtypes of breast cancer with histological grade and lymph node metastases inIndonesian woman[J]. Asian Pac J Cancer Prev, 2018, 19(5): 1263-1268. DOI: 10.22034/APJCP.2018.19.5.1263.
[2]
Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world[J]. Breast Cancer (Dove Med Press), 2019, 11: 151-164. DOI: 10.2147/BCTT.S176070.
[3]
Davey MG, Hynes SO, Kerin MJ, et al. Ki-67 as a prognostic biomarker in invasive breast cancer[J]. Cancers (Basel), 2021, 13(17): 4455. DOI: 10.3390/cancers13174455.
[4]
Jansen SA, Fan XB, Karczmar GS, et al. Differentiation between benign and malignant breast lesions detected by bilateral dynamic contrast-enhanced MRI: a sensitivity and specificity study[J]. Magn Reson Med, 2008, 59(4): 747-754. DOI: 10.1002/mrm.21530.
[5]
Warntjes JB, Dahlqvist O, Lundberg P. Novel method for rapid, simultaneous T1, T2*, and proton density quantification[J]. Magn Reson Med, 2007, 57(3): 528-537. DOI: 10.1002/mrm.21165.
[6]
Fujita S, Nakazawa M, Hagiwara A, et al. Estimation of gadolinium-based contrast agent concentration using quantitative synthetic MRI and its application to brain metastases: a feasibility study[J]. Magn Reson Med Sci, 2019, 18(4): 260-264. DOI: 10.2463/mrms.mp.2018-0119.
[7]
Duchaussoy T, Budzik JF, Norberciak L, et al. Synthetic T2 mapping is correlated with time from stroke onset: a future tool in wake-up stroke management?[J]. Eur Radiol, 2019, 29(12): 7019-7026. DOI: 10.1007/s00330-019-06270-0.
[8]
Lee SM, Choi YH, You SK, et al. Age-related changes in tissue value properties in children: simultaneous quantification of relaxation times and proton density using synthetic magnetic resonance imaging[J]. Invest Radiol, 2018, 53(4): 236-245. DOI: 10.1097/RLI.0000000000000435.
[9]
Maekawa T, Hagiwara A, Hori M, et al. Effect of gadolinium on the estimation of myelin and brain tissue volumes based on quantitative synthetic MRI[J]. AJNR Am J Neuroradiol, 2019, 40(2): 231-237. DOI: 10.3174/ajnr.A5921.
[10]
Yi J, Lee YH, Song HT, et al. Clinical feasibility of synthetic magnetic resonance imaging in the diagnosis of internal derangements of the knee[J]. Korean J Radiol, 2018, 19(2): 311-319. DOI: 10.3348/kjr.2018.19.2.311.
[11]
Kumar NM, Fritz B, Stern SE, et al. Synthetic MRI of the knee: phantom validation and comparison with conventional MRI[J]. Radiology, 2018, 289(2): 465-477. DOI: 10.1148/radiol.2018173007.
[12]
Cui YD, Han SY, Liu M, et al. Diagnosis and grading of prostate cancer by relaxation maps from synthetic MRI[J]. J Magn Reson Imaging, 2020, 52(2): 552-564. DOI: 10.1002/jmri.27075.
[13]
Liu L, Yin B, Shek K, et al. Role of quantitative analysis of T2 relaxation time in differentiating benign from malignant breast lesions[J]. J Int Med Res, 2018, 46(5): 1928-1935. DOI: 10.1177/0300060517721071.
[14]
Matsuda M, Tsuda T, Ebihara R, et al. Enhanced masses on contrast-enhanced breast: differentiation using a combination of dynamic contrast-enhanced MRI and quantitative evaluation with synthetic MRI[J]. J Magn Reson Imaging, 2021, 53(2): 381-391. DOI: 10.1002/jmri.27362.
[15]
Krauss W, Gunnarsson M, Andersson T, et al. Accuracy and reproducibility of a quantitative magnetic resonance imaging method for concurrent measurements of tissue relaxation times and proton density[J]. Magn Reson Imaging, 2015, 33(5): 584-591. DOI: 10.1016/j.mri.2015.02.013.
[16]
Li Q, Xiao Q, Yang M, et al. Histogram analysis of quantitative parameters from synthetic MRI: correlations with prognostic factors and molecular subtypes in invasive ductal breast cancer[J]. Eur J Radiol, 2021, 139: 109697. DOI: 10.1016/j.ejrad.2021.109697.
[17]
Liang CS, Cheng ZX, Huang YQ, et al. An MRI-based radiomics classifier for preoperative prediction of ki-67 status in breast cancer[J]. Acad Radiol, 2018, 25(9): 1111-1117. DOI: 10.1016/j.acra.2018.01.006.
[18]
Zhu XZ, Chen L, Huang BH, et al. The prognostic and predictive potential of Ki-67 in triple-negative breast cancer[J]. Sci Rep, 2020, 10(1): 225. DOI: 10.1038/s41598-019-57094-3.
[19]
Yuen S, Monzawa S, Yanai S, et al. The association between MRI findings and breast cancer subtypes: focused on the combination patterns on diffusion-weighted and T2-weighted images[J]. Breast Cancer, 2020, 27(5): 1029-1037. DOI: 10.1007/s12282-020-01105-z.
[20]
Nielsen TO, Leung SCY, Rimm DL, et al. Assessment of Ki67 in breast cancer: updated recommendations from the international Ki67 in breast cancer working group[J]. J Natl Cancer Inst, 2021, 113(7): 808-819. DOI: 10.1093/jnci/djaa201.
[21]
Cabrera-Galeana P, Muñoz-Montaño W, Lara-Medina F, et al. Ki67 changes identify worse outcomes in residual breast cancer tumors after neoadjuvant chemotherapy[J]. Oncologist, 2018, 23(6): 670-678. DOI: 10.1634/theoncologist.2017-0396.
[22]
Wang YB, Ikeda DM, Narasimhan B, et al. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression[J]. Radiology, 2008, 246(2): 367-375. DOI: 10.1148/radiol.2462070169.
[23]
Matsuda M, Kido T, Tsuda T, et al. Utility of synthetic MRI in predicting the Ki-67 status of oestrogen receptor-positive breast cancer: a feasibility study[J]. Clin Radiol, 2020, 75(5): 398.e1-398.e8. DOI: 10.1016/j.crad.2019.12.021.
[24]
Jung Y, Gho SM, Back SN, et al. The feasibility of synthetic MRI in breast cancer patients: comparison of T2 relaxation time with multiecho spin echo T2 mapping method[J]. Br J Radiol, 2018, 92(1093): 20180479. DOI: 10.1259/bjr.20180479.
[25]
Koyama H, Kobayashi N, Harada M, et al. Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment[J]. Am J Pathol, 2008, 172(1): 179-193. DOI: 10.2353/ajpath.2008.070360.
[26]
Kubota K, Ogawa Y, Nishioka A, et al. Radiological imaging features of invasive micropapillary carcinoma of the breast and axillary lymph nodes[J]. Oncol Rep, 2008, 20(5): 1143-1147.
[27]
Chen Q, Shen YY, Cai Q, et al. The correlation between the MRI performance of breast cancer and biological factors CerbB-2, ki-67[J]. J Clin Radiol, 2016, 35(10): 1486-1489. DOI: 10.13437/j.cnki.jcr.2016.10.010.
[28]
Suo ST, Cheng F, Cao MQ, et al. Multiparametric diffusion-weighted imaging in breast lesions: association with pathologic diagnosis and prognostic factors[J]. J Magn Reson Imaging, 2017, 46(3): 740-750. DOI: 10.1002/jmri.25612.
[29]
Martincich L, Deantoni V, Bertotto I, et al. Correlations between diffusion-weighted imaging and breast cancer biomarkers[J]. Eur Radiol, 2012, 22(7): 1519-1528. DOI: 10.1007/s00330-012-2403-8.
[30]
Li Q, Niu QL, Du HW, et al. Correlative study of MRI morphological features, ADC and expression of ki-67 in invasive breast cancer[J]. J Clin Radiol, 2017, 36(8): 1097-1100. DOI: 10.13437/j.cnki.jcr.2017.08.011.

PREV Differentiating salivary gland pleomorphic adenoma from basal cell adenoma based on multimodal magnetic resonance imaging radiomics
NEXT The reproducibility of liver stiffness from magnetic resonance elastography under confounding factors in patients with chronic liver disease
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn